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A 18-year-old male was referred to our hospital 
due to exercise angina of recent onset. Ten years 
prior to this the referral the patient had been diag-
nosed with Kawasaki disease (KD). At the time of 
diagnosis routine anti-inflammatory treatment for 
KD, which consisted of intravenous gamma globulin 
(2 g/kg) and high-dose aspirin (80 mg/kg) was admin-
istered. Echocardiography performed on the 10th day 
of treatment showed aneurysmal dilatations of the 
left coronary artery (LCA). The patient was finally 
discharged with low-dose aspirin (5 mg/kg). A coro-
nary angiography scheduled 6 months later revealed 
multiple giant aneurysms of the LCA and occlusion 
of the right coronary artery (RCA). The dimensions 
of the largest aneurysm were approximately 15 mm 
× 15 mm × 27 mm (Fig. 1A–C). These angiographic 
findings required implementation of warfarin along 
with aspirin. Following treatment, the patient did not 
present with any symptoms for a decade.
On admission at our hospital, resting electro-
cardiogram (ECG) did not reveal any abnormalities 
and laboratory work up was within normal range 
(no elevation of troponins). The echocardiogra-
phy showed normal left ventricle function. The 
exercise ECG stress test demonstrated profound 
ST-segment depression in leads I, aVL, and V4–V6. 
Subsequent coronary angiography revealed occlu-
sions within heavily calcified aneurysms in the left 
anterior descending artery (LAD) and the obtuse 
marginal branch of the LCA, as well as lingering 
RCA occlusion (Fig. 1D–F) despite anticoagulant 
treatment. The patient was consequently referred 
for a surgical total arterial coronary revasculariza-
tion using bilateral internal mammary arteries 
Y-graft to the LAD and the posterior descending 
artery. The surgery was uneventful and resulted 
in complete symptoms resolution.
Kawasaki disease is an acute self-limiting 
childhood inflammatory disease associated with 
vasculitis, which predominantly affects coronary 
arteries. Cardiovascular manifestations are the 
leading cause of long-term morbidity and mortal-
ity. Coronary artery aneurysms (CAA) develop 
in 15–25% of untreated children. However, it is 
reduced to 7% when appropriate treatment is ini-
tiated within 10 days after fever onset [1]. CAA’s 
were noted in 7.9% of patients younger than 40 
years who underwent coronary angiography due to 
symptoms of myocardial ischemia, and in 85% of 
them history of KD was probable or definitive [2]. 
On the other hand, CAA frequently remains clini-
cally silent for decades. Notwithstanding, they 
carry a lifelong risk for coronary artery thrombosis 
and myocardial ischemia or infarction. Lifelong 
aspirin is recommended in patients with KD who 
develop any kind of coronary artery dilatations. 
A combination of aspirin and oral anticoagulant 
should be recommended in patients with medium 
or giant CAA and those with a history of myocardial 
infarction [3]. The aforementioned case presents 
a well-documented natural history of KD complicat-
ed by giant CAA’s and their subsequent occlusion. 
Knowledge of the unique therapeutic challenges 
associated with KD is of great importance for the 
physicians who may come across young adults 
complaining of chest pain.
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Figure 1. A, B. First angiography, left coronary artery (LCA): aneurysms (arrows) of the left anterior descending artery 
(LAD), aneurysm (thick arrow) of the obtuse marginal branch (OM), and aneurysms (thin arrows) of the continuous 
branch of the left circumflex branch (LCx); C. First angiography, right coronary artery (RCA): proximal RCA occlusion 
(thin arrow) with developed collateral vasculature; D. Second angiography, LCA: proximal occlusion of the LAD (ar-
row) with aneurysm cavity completely filled with partially calcified thrombus (asterisk); occlusion of the OM at the 
site of previous aneurysm (thick arrow) and patent continuous branch of the LCx with aneurysms partially filled with 
thrombus (thin arrows); E, F. Second angiography, RCA: lingering RCA occlusion (thin arrow) beyond takeoff of the 
acute marginal branch (thick arrow), which supplies via collaterals the distal part of the occluded LAD (arrow).
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